Becton Dickinson Settles Majority of Hernia Litigation
Company Announcements

Becton Dickinson Settles Majority of Hernia Litigation

Becton Dickinson ( (BDX) ) just unveiled an update.

BD (Becton, Dickinson and Company), a prominent medical technology firm, has announced a settlement to resolve the majority of its hernia litigation without admitting liability or wrongdoing. The settlement, accounted for within BD’s existing litigation reserves, will be paid over several years, aligning with the company’s financial strategies and free cash flow objectives. Despite the agreement, BD remains committed to defending itself against unresolved cases and continues to assert the safety and efficacy of its products.

For a thorough assessment of BDX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyBecton Dickinson announces strategic collaboration with Ypsomed
TheFlyICU Medical initiated with a Hold at Jefferies
TheFlyTela Bio’s OviTex ‘primary beneficiary’ of BD settlement, says Lake Street
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App